The MAJESTIC Clinical Trial 12-month results evaluating the Eluvia Drug-Eluting Stent were recently presented at CIRSE

• 96.1% primacy patency at 12 months
• 94% of patients with no or minimal claudication at 12 months
• No stent fractures at 12 months

---

VIEW OUR DRUG ELUTION WEBCAST

Revolutionize your Practice: New Data to Shape the Era of Drug Elution

Featuring:

Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany

Stefan Müller-Hülsbeck, MD Diako Hospital Rensburg, Germany

William Gray, MD Columbia University Medical Center New York, New York